1. Home >
  2. M&A >
  3. PIPE >
  4. United States >
  5. California >
  6. Consonance Capital Partners Invests In Surrozen

Investment Summary

Consonance Capital Partners Invests In Surrozen

On April 15, 2021, private equity firm Consonance Capital Partners invested in life science company Surrozen

Investment Highlights
  • This is Consonance Capital Partners’ 2nd transaction in the Life Science sector.
  • This is Consonance Capital Partners’ 9th transaction in the United States.
  • This is Consonance Capital Partners’ 1st transaction in California.

Investment Summary
Date 2021-04-15
Target Surrozen
Sector Life Science
Investor(s) Consonance Capital Partners
Deal Type PIPE
Advisor(s) Guggenheim Securities
Stifel (Financial)
Cooley (Legal)

Target

Surrozen

South San Francisco, California, United States
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Surrozen is based in South San Francisco, California.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Consonance Capital Partners

Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Consonance Capital Partners is a healthcare-focused private investment firm focused on both public and private equity investing. The Firm's private equity group targets growth equity, leveraged buyouts, and recapitalization transactions in lower middle-market companies with $25 to $500 million of revenue. Specific areas of interest include healthcare providers, mayors, distribution, medical devices, specialty pharmaceuticals, outsourced services, and healthcare IT. Consonance Capital Partners was formed in 2005 and is based in New York City.

DEAL STATS #
Overall 9 of 9
Sector: Life Science M&A 2 of 2
Type: PIPE M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 9 of 9
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-04 Turn-Key Health

Philadelphia, Pennsylvania, United States

Turn-Key Health is a community-based palliative care company serving health plans, hospitals, and physicians. Turn-Key Health is based in Philadelphia, Pennsylvania.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-11-07 CityMD

New York, New York, United States

CityMD is an urgent care provider founded by a passionate group of emergency medicine physicians, CityMD's mission is to serve its communities by providing quality medical care through convenient access and an exceptional experience. The company's unwavering commitment to treating everyone with respect and genuine kindness while offering exceptional services and a cost-effective alternative to the ER. CityMD was founded in 2010 and is based in New York City.

Sell -
Mergr

Product

Company

Legal